Patrick Wen, MD
Neurology · Boston, MANPI 1053393496
Payments from drug & device makers
Across 718 payments — averaging $25,400 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$5.2M
- Servier Bioinnovation$5.1M
- Merck$4.7M
- AstraZeneca$1.5M
- Novartis$553K
- Agios Pharmaceuticals, Inc.$434K
- plus $799K from 18 others
Across 31 payments — averaging $12,975 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$383K
- Servier Bioinnovation$8K
- Servier Affaires Medicales$7K
- Servier Pharmaceuticals LLC$1K
- Novartis Pharma AG$1K
- Novartis$1K
- plus $500 from 1 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 58 | $5,230,919 |
| Servier Bioinnovation | 375 | $5,059,247 |
| Merck | 52 | $4,689,184 |
| AstraZeneca | 35 | $1,472,577 |
| Novartis | 21 | $552,577 |
| Agios Pharmaceuticals, Inc. | 86 | $433,951 |
| Bristol Myers Squibb | 2 | $342,198 |
| Karyopharm Therapeutics Inc. | 19 | $141,207 |
| Astrazeneca UK Limited | 3 | $114,942 |
| Jazz Pharmaceuticals Inc. | 8 | $53,138 |
| Bayer | 11 | $44,028 |
| Beigene, Ltd. | 6 | $28,980 |
| Servier Affaires Medicales | 8 | $19,692 |
| Novocure Inc. | 10 | $15,800 |
| E.r. Squibb & Sons, L.L.C. | 7 | $9,697 |
| GSK | 3 | $5,800 |
| Blue Earth Diagnostics | 3 | $5,775 |
| Boehringer Ingelheim | 1 | $5,445 |
| Kadmon Corporation LLC | 1 | $3,500 |
| Telix Pharmaceuticals | 3 | $3,064 |
| Novartis Pharma AG | 1 | $1,533 |
| Biogen | 2 | $1,508 |
| Rigel Pharmaceuticals, Inc. | 1 | $1,500 |
| Insightec,inc | 2 | $788 |
How this compares
$18,237,050 in reported general payments places this provider in the 95th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Boston
- Stephanie RutrickBoston$31.4M
- Scott PlotkinBoston$26.3M
- James BerryBoston$8.9M
- Isabel Arrillaga-RomanyBoston$8.2M
- Mahmut GurolBoston$7.4M
- Gad MarshallBoston$6M
- Shawn MurphyBoston$5.9M
- Suma BabuBoston$5.8M
- Luis Gonzalez CastroBoston$5.7M
- Tanuja ChitnisBoston$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.